Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation
Stanford University
Stanford University
City of Hope Medical Center
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
Virginia Commonwealth University
Masonic Cancer Center, University of Minnesota
Gruppo Italiano Malattie EMatologiche dell'Adulto
Roswell Park Cancer Institute
Rutgers, The State University of New Jersey
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
Fred Hutchinson Cancer Center
University of Chicago
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Stanford University
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
University of Washington
Alliance for Clinical Trials in Oncology
Fred Hutchinson Cancer Center
Gruppo Italiano Malattie EMatologiche dell'Adulto
Wake Forest University Health Sciences
Case Comprehensive Cancer Center
City of Hope Medical Center
Stichting Hemato-Oncologie voor Volwassenen Nederland
Alliance for Clinical Trials in Oncology
King Faisal Specialist Hospital & Research Center
Asan Medical Center
Case Comprehensive Cancer Center
University Health Network, Toronto
Roswell Park Cancer Institute
University of Colorado, Denver
University of Rochester
University of California, San Francisco
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Swiss Cancer Institute
The Cleveland Clinic
H. Lee Moffitt Cancer Center and Research Institute
Barbara Ann Karmanos Cancer Institute
Northwestern University
Northwestern University
Northwestern University
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center